EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Present and Future of Laser Interstitial Thermal Therapy in Epilepsy Surgery

Robert E Gross, Hai Sun, Ashley L B Raghu, Arevik Abramyan

Stereotactic and Functional Neurosurgery · 2025

DOI: 10.1159/000547794 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stereotactic and Functional Neurosurgery, 2025. Verfasst von Robert E Gross und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA. Hauptthemen laut MEDLINE: Laser Therapy, Drug Resistant Epilepsy, Epilepsy, Neurosurgical Procedures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 105 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: In the 15 years since the first patient with drug-resistant epilepsy was treated by MR-guided laser interstitial thermal therapy (LITT), it has revolutionized the surgical treatment of epilepsy. Therapeutic targets have ranged from every form of epileptogenic lesion, including mesial temporal sclerosis (MTS), hypothalamic hamartomas (HHs), malformations of cortical development, low-grade epilepsy-associated tumors, and cerebral cavernous malformations (CCM), to MRI-normal epileptogenic zones characterized by stereoelectroencephalography (SEEG), to disconnection surgeries such as corpus callosotomy and even functional hemispherotomy (FH). Many series now support the general effectiveness and safety of LITT for epilepsy, although we are still in the period where increasing experience and technical advances are driving refinement in the therapy. Here, we provide a broad survey of the landscape of LITT for epilepsy and a perspective on future developments. Summary: The largest experience is with stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy (MTLE), leading to seizure freedom (Engel I) in 57% of patients (N = 554), less effective than anterior temporal lobectomy but with significantly improved cognitive outcomes. Seizure-free rates are about 10% higher for MTS, with lower rates in MRI-normal MTLE. The largest experience in epileptogenic lesions is with HH where a pooled analysis found 77% of patients became seizure-free (N = 374), with up to 93% of patients becoming free of gelastic seizures. Experience with other lesions is more limited, with seizure freedom in 59% of patients with focal cortical dysplasias (N = 37), 80% of patients with periventricular nodular heterotopias (N = 39), and 88% of patients with CCMs (N = 39); 54% of patients with cortical tubers achieved Engel I or II outcomes. Outcomes in patients undergoing stereotactic laser corpus callosotomy (N = 82) or FH (N = 6) are similar to the results of open surgery. Key Messages: MR-guided LITT is becoming well established as a minimally invasive option for the treatment of drug-resistant epilepsy. While seizure freedom may in some circumstances be less than open resection, it offers improved therapeutic windows and, in some circumstances, provides surgical options where none existed previously. Moreover, it marries well with SEEG to offer a completely minimally invasive option. This combined with the increased therapeutic window and the lower level of surgical complications, pain, and even cost lowers the barrier to a potentially definitive surgical option for patients that have heretofore been reluctant. The future will see increased experience and technical advances in both laser technology and stereotactic delivery driving rapid global spread of LITT as a surgical tool in epilepsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Laser TherapyDrug Resistant EpilepsyEpilepsyNeurosurgical ProceduresHumansEpilepsy, Temporal LobeStereotaxic TechniquesMagnetic Resonance Imaging

Stichwörter der Autor:innen

Anterior temporal lobectomyCallosotomyCavernous malformationHamartomaHemispherotomyLaserPeriventricular nodular heterotopiaResection

Autor:innen und Institutionen

  • Department of Neurosurgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
  • Department of Neurosurgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA.

Zitieren

APA

Gross, R. E., Sun, H., Raghu, A. L. B., & Abramyan, A. (2025). The Present and Future of Laser Interstitial Thermal Therapy in Epilepsy Surgery. Stereotactic and Functional Neurosurgery. https://doi.org/10.1159/000547794

Vancouver

Gross RE, Sun H, Raghu ALB, Abramyan A. The Present and Future of Laser Interstitial Thermal Therapy in Epilepsy Surgery. Stereotactic and Functional Neurosurgery. 2025. doi:10.1159/000547794

BibTeX
@article{Gross2025,
  author = {Gross, Robert E and Sun, Hai and Raghu, Ashley L B and Abramyan, Arevik},
  title = {The Present and Future of Laser Interstitial Thermal Therapy in Epilepsy Surgery},
  journal = {Stereotactic and Functional Neurosurgery},
  year = {2025},
  doi = {10.1159/000547794}
}
Kostenlos starten →